This challenging 2001 book reviews modern neurotherapeutics from the point of view of drug targeting.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Anbieter: Grand Eagle Retail, Bensenville, IL, USA
Paperback. Zustand: new. Paperback. The thesis of this innovative and challenging book, first published in 2001, is that brain drug development has been restricted by the failure of adequate brain drug targeting, and that this is an increasingly urgent problem as developments in genomics lead to new generations of therapeutic macromolecules. The author, a world leader in the study of the blood-brain barrier and its clinical implications, reviews the field of neurotherapeutics from the point of view of drug targeting. He surveys the scientific and clinical basis of drug delivery across biological membranes, including topics such as genetically engineered trojan horses for drug targeting, antisense neurotherapeutics, and gene therapy of brain disorders. At a time when there are few significant new drug treatments in prospect for common neurological diseases, this authoritative review will encourage a wide range of clinicians and neuroscientists to reexamine the development and use of drugs in treating disorders of the central nervous system. This challenging 2001 book reviews modern neurotherapeutics from the point of view of drug targeting, surveying the scientific and clinical basis of drug delivery across biological membranes. It will encourage a wide range of clinicians and neuroscientists to reexamine the use of drugs in treating disorders of the central nervous system. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. Bestandsnummer des Verkäufers 9780521154468
Anbieter: California Books, Miami, FL, USA
Zustand: New. Bestandsnummer des Verkäufers I-9780521154468
Anzahl: Mehr als 20 verfügbar
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
Paperback. Zustand: Brand New. reissue edition. 353 pages. 9.75x7.00x0.75 inches. In Stock. This item is printed on demand. Bestandsnummer des Verkäufers __0521154464
Anzahl: 1 verfügbar
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
Zustand: New. In. Bestandsnummer des Verkäufers ria9780521154468_new
Anzahl: Mehr als 20 verfügbar
Anbieter: Chiron Media, Wallingford, Vereinigtes Königreich
PF. Zustand: New. Bestandsnummer des Verkäufers 6666-IUK-9780521154468
Anzahl: 10 verfügbar
Anbieter: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irland
Zustand: New. This challenging 2001 book reviews modern neurotherapeutics from the point of view of drug targeting. Num Pages: 376 pages, black & white illustrations. BIC Classification: MJN; MMGW. Category: (P) Professional & Vocational. Dimension: 244 x 170 x 20. Weight in Grams: 600. . 2010. Reissue. paperback. . . . . Bestandsnummer des Verkäufers V9780521154468
Anzahl: Mehr als 20 verfügbar
Anbieter: Books Puddle, New York, NY, USA
Zustand: New. pp. 376. Bestandsnummer des Verkäufers 26615854
Anzahl: 4 verfügbar
Anbieter: Majestic Books, Hounslow, Vereinigtes Königreich
Zustand: New. Print on Demand pp. 376 67:B&W 6.69 x 9.61 in or 244 x 170 mm (Pinched Crown) Perfect Bound on White w/Gloss Lam. Bestandsnummer des Verkäufers 8313457
Anzahl: 4 verfügbar
Anbieter: Kennys Bookstore, Olney, MD, USA
Zustand: New. This challenging 2001 book reviews modern neurotherapeutics from the point of view of drug targeting. Num Pages: 376 pages, black & white illustrations. BIC Classification: MJN; MMGW. Category: (P) Professional & Vocational. Dimension: 244 x 170 x 20. Weight in Grams: 600. . 2010. Reissue. paperback. . . . . Books ship from the US and Ireland. Bestandsnummer des Verkäufers V9780521154468
Anzahl: Mehr als 20 verfügbar
Anbieter: Biblios, Frankfurt am main, HESSE, Deutschland
Zustand: New. PRINT ON DEMAND pp. 376. Bestandsnummer des Verkäufers 18615844
Anzahl: 4 verfügbar